Tenofovir

规格

147127-20-6CAS 号

604-571-2EC 号

[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acidIUPAC 名称

C9H14N5O4P化学式

287.21 g/mol分子量

Tenofovir; 147127-20-6; (R)-9-(2-Phosphonomethoxypropyl)adenine; (R)-PMPA; tenofovir (anhydrous); Tenofovir anhydrous; GS-1275; anhydrous tenofovir; tenofovir (anh.); GS-1278; CHEBI:63625; ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid; W4HFE001U5; (R)-9-(Phosphonomethoxypropyl)adenine; [(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid; (R)-9-(2-Phosphonylmethoxypropyl)adenine; PMP-A; DTXSID9040132; (((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid; Phosphonic acid, (((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-; CHEBI:63716; tenofovirum; ((2R)-1-(6-aminopurin-9-yl)propan-2-yl)oxymethylphosphonic acid; ((((2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic acid; {[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonic acid; Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-; Disoproxil, Tenofovir; 9-PMPA (tenofovir); RefChem:6288; Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, monohydrate, (R)-; Disoproxil Fumarate, Tenofovir; Fumarate, Tenofovir Disoproxil; DTXCID7020132; J05AF07; 9-(2-Phosphonylmethoxypropyl)adenine; (R)-9-(Phosphonomethoxypropyl)adenine Hydrate; (R)-9-(2-Phosphonomethoxypropyl)adenine Hydrate; (((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic Acid, Monohydrate; 9-(2-Phosphonomethoxypropyl)adenine; 99YXE507IL; PMPA; tenofovir monohydrate; Truvada; (R)-(((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID; PMPA gel; MFCD00943794; Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-; C9H14N5O4P; [(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methylphosphonic acid; 9-[(R)-2-(phosphonomethoxy)propyl]adenine; (R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid; D,L-Tenofovir; Rac tenofovir; (R)-9-[2-(Phosphonomethoxy)propyl]adenine; Tenofovir (1.0 mg/mL in Water); Tenofovir gel; [[(1R)-2(6-Amino-9H-Purin-9-Yl)-1-Methylethoxy]Methyl]Phosphonic Acid; [2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID; GNA & Tenofovir; HHA & Tenofovir; TFV gel; TFV; GS 1275; PMPA-(R); UNII-W4HFE001U5; Tenofovir [USAN:INN:BAN]; anh. tenofovir; Apropovir;; Viread (prodrug for Tenofovir); [[(1R)-2(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid;; Viread;; 9-[2-(phosphonomethoxy)propyl]adenine; PHOSPHONIC ACID, P-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-; 147127-20-6 (Tenofovir); Tenofovir (Viread); KS-5021; TENOFOVIR [INN]; TENOFOVIR [MI]; (R)-9-(2-Phosphonoylmethoxypropyl)adenine; 9-PMPA; CHEMBL483; Epitope ID:231722; EC 604-571-2; TENOFOVIR [WHO-DD]; SCHEMBL39724; orb533302; Tenofovir gel (GS-1278); Tenofovir - Bio-X trade mark; orb1307900; orb3141202; SCHEMBL29355255; Tenofovir (1 mg/mL in Water); Tenofovir, >=98% (HPLC); GTPL10948; SGOIRFVFHAKUTI-ZCFIWIBFSA-N; GLXC-07808; HMS3264H05; MSK10872; AC-760; BDBM50450813; EBC-02044; MFCD07357269; (R)-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid; AKOS015856701; AKOS015894941; CCG-267345; CS-1609; DB14126; FT10480; (R)-[[2-(6-Amino-9H-purin-9-; Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, (R)-; NCGC00167535-16; BT164455; HY-13910; SY046605; NS00000521; (R)-9-[2-(phosphonomethoxy) propyl] adenine; C17407; EN300-123033; AB01274787-01; AB01274787_02; AB01274787_03; F077792; Q155954; SR-01000883934; SR-01000883934-1; BRD-K15891719-001-02-8; BRD-K15891719-001-04-4; BRD-K15891719-001-05-1; BRD-K15891719-213-01-1; Z1546616194; 1-(6-aminopurin-9-yl)propan-2- yloxymethylphosphonic acid; (R)-[[(1-(6-Amino-9-purinyl)-2-propyl)oxy]methyl]phosphonic Acid; Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA); Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA); TFO同义词